Group A for Abdominal Fat

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cynosure, Inc., Westford, MA
Abdominal Fat+1 More
Brera - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The intended use of the device in this study to assess the safety and efficacy of the adhesive electrodes for muscle stimulation and the treatment of abdominal fat on the abdomen and/or flanks.

Eligible Conditions

  • Abdominal Fat
  • Muscle Stimulation

Treatment Effectiveness

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: 90 day follow up

30 day follow up
% Of Photographs Identified Correctly (Comparing Baseline vs. 30 days)
Percent Of Photographs Identified Correctly (Comparing Baseline vs. 30 days)
90 day follow up
% Of Photographs Identified Correctly (Comparing Baseline vs. 90 days)
Percent Of Photographs Identified Correctly (Comparing Baseline vs. 90 days)

Trial Safety

Trial Design

2 Treatment Groups

Group A
1 of 2
Group B
1 of 2
Experimental Treatment

30 Total Participants · 2 Treatment Groups

Primary Treatment: Group A · No Placebo Group · N/A

Group A
Device
Experimental Group · 1 Intervention: Brera · Intervention Types: Device
Group B
Device
Experimental Group · 1 Intervention: Brera · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 90 day follow up
Closest Location: Cynosure, Inc. · Westford, MA
2022First Recorded Clinical Trial
1 TrialsResearching Abdominal Fat
1 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a healthy male or female.\n
You agree to be treated with the Brera/Med 400 device.
You understand and accept the obligation not to receive any other procedures on the treatment area through the length of the study.
You understand and accept the obligation to be present for all visits.
You are willing to comply with all requirements of the study and sign the informed consent document.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.